Incomplete penetrance in limb-girdle muscular dystrophy type 1F.

作者信息

Fanin Marina, Peterle Enrico, Fritegotto Chiara, Nascimbeni Anna C, Tasca Elisabetta, Torella Annalaura, Nigro Vincenzo, Angelini Corrado

机构信息

Department of Neurosciences, University of Padova, Padova, Italy.

IRCCS Fondazione San Camillo Hospital, Venice, Italy.

出版信息

Muscle Nerve. 2015 Aug;52(2):305-6. doi: 10.1002/mus.24539. Epub 2015 Jun 7.

DOI:10.1002/mus.24539

PMID:25487718

Abstract

摘要

相似文献

Incomplete penetrance in limb-girdle muscular dystrophy type 1F.

Muscle Nerve. 2015 Aug;52(2):305-6. doi: 10.1002/mus.24539. Epub 2015 Jun 7.

Incomplete penetrance in the Spanish family with limb-girdle muscular dystrophy type 1F.

Muscle Nerve. 2016 Jan;53(1):156-7. doi: 10.1002/mus.24900. Epub 2015 Sep 23.

Limb-girdle muscular dystrophy 1F is caused by a microdeletion in the transportin 3 gene.

Brain. 2013 May;136(Pt 5):1508-17. doi: 10.1093/brain/awt074. Epub 2013 Mar 29.

The limb-girdle muscular dystrophies.

Neurol Clin. 2014 Aug;32(3):729-49, ix. doi: 10.1016/j.ncl.2014.04.005.

Reply.

Muscle Nerve. 2016 Jan;53(1):157-8. doi: 10.1002/mus.24898. Epub 2015 Nov 26.

Limb-girdle muscular dystrophy type 2A resulting from homozygous G2338C transversion mutation in the calpain-3 gene.

J Clin Neuromuscul Dis. 2010 Dec;12(2):62-5. doi: 10.1097/CND.0b013e3181f3dbd3.

Limb-girdle muscular dystrophies: heterogeneity of clinical phenotypes and pathogenetic mechanisms.

Acta Myol. 2004 Dec;23(3):130-6.

Expanding the phenotype of GMPPB mutations.

Brain. 2015 Apr;138(Pt 4):836-44. doi: 10.1093/brain/awv013. Epub 2015 Feb 12.

Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I.

Arch Neurol. 2005 Dec;62(12):1894-9. doi: 10.1001/archneur.62.12.1894.

A novel pathogenic variant in TNPO3 in a Hungarian family with limb-girdle muscular dystrophy 1F.

Eur J Med Genet. 2019 Jul;62(7):103662. doi: 10.1016/j.ejmg.2019.05.001. Epub 2019 May 6.

引用本文的文献

LGMD D2 TNPO3-Related: From Clinical Spectrum to Pathogenetic Mechanism.

Front Neurol. 2022 Mar 4;13:840683. doi: 10.3389/fneur.2022.840683. eCollection 2022.

Inhibition of autophagy rescues muscle atrophy in a LGMDD2 Drosophila model.

FASEB J. 2021 Oct;35(10):e21914. doi: 10.1096/fj.202100539RR.

Circulating miR-206 as a Biomarker for Patients Affected by Severe Limb Girdle Muscle Dystrophies.

Genes (Basel). 2021 Jan 12;12(1):85. doi: 10.3390/genes12010085.

A new family with transportinopathy: increased clinical heterogeneity.

Ther Adv Neurol Disord. 2019 Jun 9;12:1756286419850433. doi: 10.1177/1756286419850433. eCollection 2019.

Novel mutation in causes congenital limb-girdle myopathy with slow progression.

Neurol Genet. 2019 May 2;5(3):e337. doi: 10.1212/NXG.0000000000000337. eCollection 2019 Jun.

Karyopherins in cancer.

Curr Opin Cell Biol. 2018 Jun;52:30-42. doi: 10.1016/j.ceb.2018.01.006. Epub 2018 Feb 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Incomplete penetrance in limb-girdle muscular dystrophy type 1F.

Muscle Nerve. 2015 Aug;52(2):305-6. doi: 10.1002/mus.24539. Epub 2015 Jun 7.

Incomplete penetrance in the Spanish family with limb-girdle muscular dystrophy type 1F.

Muscle Nerve. 2016 Jan;53(1):156-7. doi: 10.1002/mus.24900. Epub 2015 Sep 23.

Limb-girdle muscular dystrophy 1F is caused by a microdeletion in the transportin 3 gene.

Brain. 2013 May;136(Pt 5):1508-17. doi: 10.1093/brain/awt074. Epub 2013 Mar 29.

The limb-girdle muscular dystrophies.

Neurol Clin. 2014 Aug;32(3):729-49, ix. doi: 10.1016/j.ncl.2014.04.005.

Reply.

Muscle Nerve. 2016 Jan;53(1):157-8. doi: 10.1002/mus.24898. Epub 2015 Nov 26.

Limb-girdle muscular dystrophy type 2A resulting from homozygous G2338C transversion mutation in the calpain-3 gene.

J Clin Neuromuscul Dis. 2010 Dec;12(2):62-5. doi: 10.1097/CND.0b013e3181f3dbd3.

Limb-girdle muscular dystrophies: heterogeneity of clinical phenotypes and pathogenetic mechanisms.

Acta Myol. 2004 Dec;23(3):130-6.

Expanding the phenotype of GMPPB mutations.

Brain. 2015 Apr;138(Pt 4):836-44. doi: 10.1093/brain/awv013. Epub 2015 Feb 12.

Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I.

Arch Neurol. 2005 Dec;62(12):1894-9. doi: 10.1001/archneur.62.12.1894.

A novel pathogenic variant in TNPO3 in a Hungarian family with limb-girdle muscular dystrophy 1F.

Eur J Med Genet. 2019 Jul;62(7):103662. doi: 10.1016/j.ejmg.2019.05.001. Epub 2019 May 6.

引用本文的文献

LGMD D2 TNPO3-Related: From Clinical Spectrum to Pathogenetic Mechanism.

Front Neurol. 2022 Mar 4;13:840683. doi: 10.3389/fneur.2022.840683. eCollection 2022.

Inhibition of autophagy rescues muscle atrophy in a LGMDD2 Drosophila model.

FASEB J. 2021 Oct;35(10):e21914. doi: 10.1096/fj.202100539RR.

Circulating miR-206 as a Biomarker for Patients Affected by Severe Limb Girdle Muscle Dystrophies.

Genes (Basel). 2021 Jan 12;12(1):85. doi: 10.3390/genes12010085.

A new family with transportinopathy: increased clinical heterogeneity.

Ther Adv Neurol Disord. 2019 Jun 9;12:1756286419850433. doi: 10.1177/1756286419850433. eCollection 2019.

Novel mutation in causes congenital limb-girdle myopathy with slow progression.

Neurol Genet. 2019 May 2;5(3):e337. doi: 10.1212/NXG.0000000000000337. eCollection 2019 Jun.

Karyopherins in cancer.

Curr Opin Cell Biol. 2018 Jun;52:30-42. doi: 10.1016/j.ceb.2018.01.006. Epub 2018 Feb 4.